DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación
Artículo científico (JournalArticle)
Drug repurposing for COVID-19 using machine learning and mechanistic models of signal transduction circuits related to SARS-CoV-2 infection
Drug repurposing is a convenient alternative when the need for
new drugs in an unexpected medical scenario is urgent, as is the
case of emerging pathogens. In recent years, approaches based
on network biology have demonstrated to be superior to genecentric ones.1 Here, we use an innovative methodology that
combines mechanistic modeling of the signal transduction circuits
related to SARS-CoV-2 infection (the COVID-19 disease map) with a
machine-learning algorithm that learns potential causal interactions between proteins, already targets of drugs, and specific
signaling circuits in the COVID-19 disease map, to suggest
potentially repurposable drugs., This work is supported by grants SAF2017-88908-R from the Spanish Ministry of
Economy and Competitiveness, PT17/0009/0006, ACCI2018/29 from CIBER-ISCIII and
COV20/00788 from the ISCIII, co-funded with European Regional Development Funds
(ERDF), the grant “Large-scale drug repurposing in rare diseases by genomic Big Data
analysis with machine learning methods” from the Fundación BBVA (G999088Q), as well
as H2020 Programme of the European Union grants Marie Curie Innovative Training
Network “Machine Learning Frontiers in Precision Medicine” (MLFPM) (GA 813533).